CLINICAL_TRIALS
approval
· 2016-02-23
Clinical Trial Update: Athrectomy and Drug Eluting Balloon Therapy (ADEBT) on the Femoral Popliteal Arteries
Summary
The Athrectomy with Drug Eluting Balloon Therapy (ADEBT) has been approved for marketing to treat Peripheral Arterial Disease in the femoral-popliteal arteries.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Changi General Hospital | Conditions: Peripheral Arterial Disease | Status: APPROVED_FOR_MARKETING